1. Home
  2. AEMD vs SHPH Comparison

AEMD vs SHPH Comparison

Compare AEMD & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

HOLD

Current Price

$3.17

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

HOLD

Current Price

$2.58

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEMD
SHPH
Founded
1984
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.1M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
AEMD
SHPH
Price
$3.17
$2.58
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$287.50
N/A
AVG Volume (30 Days)
70.4K
7.3M
Earning Date
02-11-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$1.26
52 Week High
$64.00
$24.75

Technical Indicators

Market Signals
Indicator
AEMD
SHPH
Relative Strength Index (RSI) 55.77 66.25
Support Level $2.64 $1.80
Resistance Level $3.19 $4.44
Average True Range (ATR) 0.30 0.48
MACD 0.10 0.10
Stochastic Oscillator 87.96 41.27

Price Performance

Historical Comparison
AEMD
SHPH

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Share on Social Networks: